Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Pulmatrix Takes $14 Mil. From Insiders, Sharpens Focus On Dry-Powder Inhaler Drug

Aug 15 2011

• By The Pink Sheet Daily

Related Content

Pulmatrix Gets $30M And An NIH Grant To Develop A Broad-Spectrum Anti-Infective

Nov 02 2009

Aporkalypse Next: Pulmatrix Moves Broad-Spectrum Inhaled Anti-Infective Into Phase II

May 05 2009

Pulmatrix Inc.

Jun 01 2011

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window